Two companies to watch here. Metabolic MBP/MBPO and Circadian (who own 35% of MBP).
Metabolic should release results from oral phase 2 human trials on their anti-obesity drug within days.
Positive results will see very big reaction from the market as these trials are a very important stage in any drugs development. Earlier trials have proved it is safe and works when administered by intravenous injection. Now if it works orally it will be easily accepted by the overweight western world.
More in at the web site http://www.metabolic.com.au/
Two companies to watch here. Metabolic MBP/MBPO and Circadian...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)